Gastrointestinal Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Gastrointestinal Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-25Clinical Trial Results: Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors [Phase 2]
Phase 2 trial results for nab-sirolimus in patients with well-differentiated neuroendocrine tumors (NETs) of the gastrointestinal tract, lun…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients [Phase 1]
Phase 1 trial of Cabotamig (ARB202) in advanced gastrointestinal cancers has completed; no specific efficacy results are provided in the doc…
-
CLINICAL_TRIALS trial_result · 2019-05-24Clinical Trial Update: Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type [Phase 2]
Phase 2 trial comparing etoposide/cisplatin to irinotecan/cisplatin for advanced gastrointestinal neuroendocrine tumors/g3.
-
CLINICAL_TRIALS trial_result · 2017-10-19Clinical Trial Update: A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers [Phase 2]
Phase 2 study of Fosbretabulin in pancreatic or gastrointestinal neuroendocrine tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2009-10-07Clinical Trial Update: High Dose Somatostatin Analogues in Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating high-dose somatostatin analogues in neuroendocrine tumors has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.